Arnaud Duquet

1.6k total citations
9 papers, 1.4k citations indexed

About

Arnaud Duquet is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Arnaud Duquet has authored 9 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Genetics. Recurrent topics in Arnaud Duquet's work include Muscle Physiology and Disorders (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Protein Degradation and Inhibitors (3 papers). Arnaud Duquet is often cited by papers focused on Muscle Physiology and Disorders (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Protein Degradation and Inhibitors (3 papers). Arnaud Duquet collaborates with scholars based in France, Switzerland and Israel. Arnaud Duquet's co-authors include Ariel Ruiz i Altaba, Marie Zbinden, Annick Harel‐Bellan, Anna Polesskaya, Monica Malerba, Irina Naguibneva, Christophe Mas, Frédéric Varnat, Pascal Gervaz and Philippe Robin and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and The EMBO Journal.

In The Last Decade

Arnaud Duquet

9 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arnaud Duquet France	9	1.2k	420	271	137	95	9	1.4k
Fumiko Saito-Ohara Japan	16	941 0.8×	437 1.0×	222 0.8×	188 1.4×	41 0.4×	27	1.3k
Kannan Thirunavukkarasu United States	21	1.5k 1.3×	731 1.7×	402 1.5×	202 1.5×	42 0.4×	32	1.9k
Yaser Atlasi Netherlands	16	1.3k 1.1×	288 0.7×	212 0.8×	106 0.8×	79 0.8×	29	1.5k
Michael F. Buckley Australia	12	841 0.7×	692 1.6×	189 0.7×	275 2.0×	65 0.7×	21	1.4k
Karoline J. Briegel United States	17	720 0.6×	242 0.6×	191 0.7×	110 0.8×	64 0.7×	28	1.0k
Deepa Subramanyam India	17	1.1k 0.9×	243 0.6×	544 2.0×	75 0.5×	59 0.6×	34	1.4k
Annalisa Di Ruscio Italy	19	1.1k 0.9×	167 0.4×	307 1.1×	102 0.7×	123 1.3×	36	1.5k
Rui Fang Qiao United States	11	999 0.8×	360 0.9×	201 0.7×	116 0.8×	34 0.4×	12	1.3k
Koichi Nagasaki Japan	18	623 0.5×	303 0.7×	363 1.3×	123 0.9×	40 0.4×	31	1.1k

Countries citing papers authored by Arnaud Duquet

Since Specialization

Citations

This map shows the geographic impact of Arnaud Duquet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Duquet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Duquet more than expected).

Fields of papers citing papers by Arnaud Duquet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Duquet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Duquet. The network helps show where Arnaud Duquet may publish in the future.

Co-authorship network of co-authors of Arnaud Duquet

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Duquet. A scholar is included among the top collaborators of Arnaud Duquet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Duquet. Arnaud Duquet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Duquet, Arnaud, et al.. (2014). A novel genome‐wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT ‐ TCF pathway modulators TMED 3 and SOX 12. EMBO Molecular Medicine. 6(7). 882–901. 67 indexed citations

Zbinden, Marie, et al.. (2010). NANOG regulates glioma stem cells and is essential in vivo acting in a cross‐functional network with GLI1 and p53. The EMBO Journal. 29(15). 2659–2674. 253 indexed citations

Varnat, Frédéric, Arnaud Duquet, Monica Malerba, et al.. (2009). Human colon cancer epithelial cells harbour active HEDGEHOG‐GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Molecular Medicine. 1(6-7). 338–351. 386 indexed citations

Polesskaya, Anna, Sylvain Cuvellier, Irina Naguibneva, et al.. (2007). Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes & Development. 21(9). 1125–1138. 236 indexed citations

Duquet, Arnaud, Anna Polesskaya, Sylvain Cuvellier, et al.. (2006). Acetylation is important for MyoD function in adult mice. EMBO Reports. 7(11). 1140–1146. 25 indexed citations

Polesskaya, Anna, Irina Naguibneva, Arnaud Duquet, et al.. (2001). Interaction between Acetylated MyoD and the Bromodomain of CBP and/or p300. Molecular and Cellular Biology. 21(16). 5312–5320. 85 indexed citations

Polesskaya, Anna, Arnaud Duquet, Irina Naguibneva, et al.. (2000). CREB-binding Protein/p300 Activates MyoD by Acetylation. Journal of Biological Chemistry. 275(44). 34359–34364. 107 indexed citations

Ait‐Si‐Ali, Slimane, Anna Polesskaya, Stéphanie Filleur, et al.. (2000). CBP/p300 histone acetyl-transferase activity is important for the G1/S transition. Oncogene. 19(20). 2430–2437. 118 indexed citations

Ait‐Si‐Ali, Slimane, Sandra Ramírez‐Clavijo, Arnaud Duquet, et al.. (1999). Phosphorylation by p44 MAP Kinase/ERK1 Stimulates CBP Histone Acetyl Transferase Activity in Vitro. Biochemical and Biophysical Research Communications. 262(1). 157–162. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact